Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.57 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.57 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.53 |
| ▸ | ACACB | O00763 | 1/20 | 0.51 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.51 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.51 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.51 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7837295 | 0.92 | ALDH1A1 (0.66) | LMNAL3MBTL1ALDH1A1KMT2AMAPK1 | |
| SCHEMBL7216854 | 0.89 | ALDH1A1 (0.62) | LMNAL3MBTL1ALDH1A1KMT2AMAPK1 | |
| SCHEMBL9471180 | 0.89 | MEN1 (0.67) | LMNAALDH1A1KMT2AMAPK1MEN1 | |
| SCHEMBL6658231 | 0.87 | HRH3 (0.59) | LMNAL3MBTL1ALDH1A1KMT2AMAPK1 | |
| SCHEMBL8500363 | 0.87 | MEN1 (0.69) | LMNAALDH1A1KMT2AMAPK1MEN1 | |
| SCHEMBL7623214 | 0.87 | MEN1 (0.69) | LMNAALDH1A1KMT2AMAPK1MEN1 | |
| SCHEMBL1667156 | 0.87 | MEN1 (0.69) | LMNAALDH1A1KMT2AMAPK1MEN1 | |
| SCHEMBL12559687 | 0.87 | MEN1 (0.69) | LMNAALDH1A1KMT2AMAPK1MEN1 | |
| SCHEMBL8498228 | 0.87 | MEN1 (0.69) | LMNAALDH1A1KMT2AMAPK1MEN1 | |
| SCHEMBL10427155 | 0.87 | MEN1 (0.69) | LMNAALDH1A1KMT2AMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115210239-B | Aromatic compound, organic semiconductor layer, and organic thin film transistor | 东曹株式会社 | 2025-04-11 | — | — | CN | disclosed |
| US-20230142592-A1 | AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC THIN FILM TRANSISTOR | TOSOH CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| CN-115210239-A | Aromatic compound, organic semiconductor layer and organic thin film transistor | 东曹株式会社 | 2022-10-18 | — | — | CN | disclosed |
| US-20180057953-A1 | PLATING SOLUTION USING AMMONIUM SALT | MITSUBISHI MATERIALS CORPORATION (JP) | 2018-03-01 | — | — | US | disclosed |
| US-20180051383-A1 | PLATING SOLUTION USING PHOSPHONIUM SALT | MITSUBISHI MATERIALS CORPORATION (JP) | 2018-02-22 | — | — | US | disclosed |
| US-20180051384-A1 | PLATING SOLUTION USING SULFONIUM SALT | MITSUBISHI MATERIALS CORPORATION (JP) | 2018-02-22 | — | — | US | disclosed |
| US-8586614-B2 | Urea glucokinase activators | NOVO NORDISK A/S (DK) | 2013-11-19 | — | — | US | disclosed |
| CN-101263131-B | Urea glucokinase activators | TRANSTECH PHARMA INC | 2013-04-24 | — | — | CN | disclosed |
| EP-2377856-A1 | Urea glucokinase activators | NOVO NORDISK A/S (DK) | 2011-10-19 | — | — | EP | disclosed |
| US-20110077234-A1 | Urea Glucokinase Activators | NOVO NORDISK A/S (DK) | 2011-03-31 | — | — | US | disclosed |
| US-7884210-B2 | {2-[3-(2-Cyclohex-1-enyl-ethyl)-3-(trans-4-methyl-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid; for treatment of type 2 diabetes | NOVO NORDISK A/S (DK) | 2011-02-08 | — | — | US | disclosed |
| US-20090105482-A1 | Urea Glucokinase Activators | NOVO NORDISK A/S (DK) | 2009-04-23 | — | — | US | disclosed |
| CN-101263131-A | Urea glucokinase activators | NOVO NORDISK AS (US) | 2008-09-10 | — | — | CN | disclosed |
| EP-1904467-A1 | UREA GLUCOKINASE ACTIVATORS | Novo Nordisk A/S (DK) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007006814-A1 | UREA GLUCOKINASE ACTIVATORS | NOVO NORDISK A/S (DK) | 2007-01-18 | — | — | WO | disclosed |
| US-6627651-B1 | Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-30 | — | — | US | disclosed |
| EP-1182195-A1 | CYCLIC COMPOUNDS AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |
| US-6106999-A | SENSITIVITY TO GENERAL-PURPOSE VISIBLE LIGHT LASER, SO THAT HIGH-SPEED SCANNING EXPOSURE IS POSSIBLE BY LASER, AND EXTREMELY FINE HIGH RESOLUTION CAN BE OBTAINED; CAN BE USED FOR COATING OR PRINTING UNDER SAFELIGHT IRRADIATING CONDITIONS | MITSUI CHEMICALS (JP) | 2000-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142592-A1 | AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC THIN FILM TRANSISTOR | CHRM1, CHRM2, ACVRL1 | LMNA 2850/4885L3MBTL1 452/4885ALDH1A1 1807/4885 |
| US-20090105482-A1 | Urea Glucokinase Activators | GCK, GCKR, HK2 | LMNA 3732/4885L3MBTL1 3946/4885ALDH1A1 1040/4885 |
| US-20110077234-A1 | Urea Glucokinase Activators | GCK, GCKR, HK2 | LMNA 3732/4885L3MBTL1 3946/4885ALDH1A1 1040/4885 |
| US-20180051383-A1 | PLATING SOLUTION USING PHOSPHONIUM SALT | PPM1F, PPM1A, PSPH | LMNA 4113/4885L3MBTL1 2697/4885ALDH1A1 3065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.